Slightly tangential to GGPeps (GYC) tirzepatide but Dr.ObesityMed reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Saving this for reference. Quality thread.
Slightly tangential to GGPeps (GYC) tirzepatide but FranDenver reminded me — has anyone else noticed changes in their alcohol tolerance?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Relevant to GGPeps (GYC) tirzepatide — here is my latest bloodwork comparison:
Key improvements: A1C 7.6% → 5.5%, triglycerides 217 → 117 mg/dL, hsCRP 8.0 → 1.1 mg/L. All on tirzepatide for 9 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Want to share my personal experience related to GGPeps (GYC) tirzepatide since I think it might help others in a similar situation.
I started my GLP-1 journey in March 2025 at 273 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.
Now, 14 months later: I am down 73 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The GGPeps (GYC) aspect specifically was something that made a big difference in my journey.
This forum was my go-to resource throughout.